BioNTech SE

BNTX

Held by 1 specialist biotech fund

Share on X

Fund Holdings

Baker Bros. Advisors

AI Signal

## Signal Note: Baker Bros.

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Baker Bros. AdvisorsNEWFeb 17, 2026

Shares: 368,923Value: $35.1M

## Signal Note: Baker Bros. Initiates Large Position in BioNTech (BNTX) **Note: The reported position value of ~$35.1B appears to be a data error — 368,923 shares at recent BNTX prices (~$95-105) would be worth approximately $35-39M, not $35B. Analysis proceeds on the corrected ~$35M figure.** Baker Bros. opening a new position in BNTX is notable given their historically concentrated, conviction-driven approach focused on clinical-stage catalysts. BioNTech's pipeline inflection points center on its oncology portfolio — particularly BNT327 (PD-L1×VEGF bispecific) generating competitive data across NSCLC and TNBC with multiple Phase 3 readouts expected through 2025-2026, and its individualized neoantigen m

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

ABSI1 fund AAVXF1 fund ALGS1 fund ALKS1 fund ALMS1 fund FDMT1 fund ARGX1 fund RCUS

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: